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ABSTRACT 
The methyl donor S-adenosylmethionine is synthesized in mammalian cytosol by three 
isoenzymes. Methionine adenosyltransferase II is ubiquitously expressed, whereas isoenzymes I 
(homotetramer) and III (homodimer) are considered the hepatic enzymes. In this work, we 
identified methionine adenosyltransferase I/III in most rat tissues both in the cytoplasm and the 
nucleus. Nuclear localization was the preferred distribution observed in extrahepatic tissues, 
where the protein colocalizes with nuclear matrix markers. A battery of mutants used in several 
cell lines to decipher the determinants involved in methionine adenosyltransferase subcellular 
localization demonstrated, by confocal microscopy and subcellular fractionation, the presence of 
two partially overlapping areas at the C-terminal end of the protein involved both in cytoplasmic 
retention and nuclear localization. Immunoprecipitation of coexpressed FLAG and EGFP fusions 
and gel filtration chromatography allowed detection of tetramers and monomers in nuclear 
fractions that also exhibited S-adenosylmethionine synthesis. Neither nuclear localization nor 
matrix binding required activity, as demonstrated with the inactive F251D mutant. Nuclear 
accumulation of the active enzyme only correlated with histone H3K27 trimethylation among the 
epigenetic modifications evaluated, therefore pointing to the necessity of methionine 
adenosyltransferase I/III to guarantee the supply of S-adenosylmethionine for specific 
methylations. However, nuclear monomers may exhibit additional roles. 
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INTRODUCTION 
Control of gene expression and synthesis of adrenaline or phospholipids such as 
phosphatidylcholine are some examples of processes involving S-adenosylmethionine (AdoMet)-
dependent methylations (1). AdoMet also participates in other important reactions such as those 
catalyzed by SAM radical proteins (i.e. biotin synthesis) or, upon decarboxylation, in spermidine 
and spermine synthesis (2, 3). In fact, all the radicals surrounding the AdoMet sulfur atom can be 
donated, as well as the carboxyl and amino groups of the methionine and the ribosyl moiety (4, 
5). Thus, the number of processes involving AdoMet has been calculated to be as large as that of 
reactions using ATP. This small positively charged compound is synthesized from methionine 
and ATP in a singular reaction catalyzed by methionine adenosyltransferases (MATs)(6). These 
enzymes are present in the cytoplasm of eukaryotic cells (2), though reactions using this 
compound exhibit a wider subcellular distribution. Transfer of AdoMet to other cell 
compartments is therefore needed and carried out by specific transporters (7). Changes in 
AdoMet levels have been detected in several diseases, ranging from Parkinson (8) to alcohol 
liver cirrhosis (9). However, a direct correlation between AdoMet levels and pathology was only 
obtained by generating MAT1A knockout mice, which spontaneously develop hepatocellular 
carcinoma (HCC)(10).  
Sequences for MAT catalytic subunits are highly conserved in all organisms (11), except 
in Archaea (12). This strong conservation is also observed at the structural level, with monomers 
composed by three domains formed by non-consecutive stretches of the sequence (13). General 
properties of these proteins include their association into oligomers to form the intersubunit 
active sites and their tripolyphosphatase activity. In mammals, three isoenzymes have been 
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detected, one ubiquitous (MAT II) and two others considered to be liver-specific (MAT I and III). 
MAT II is believed to be a heterotetramer (α2β)2, where α2 is the catalytic subunit and β is the 
regulatory subunit, encoded by the MAT2A and MAT2B genes, respectively (14). On the other 
hand, MAT I is a homotetramer, and MAT III is a homodimer, of a α1 subunit that is 396 amino 
acids long and is codified by the MAT1A gene (2). These isoenzymes differ in their affinities for 
methionine, an important fact in human liver, where 48% of the ingested amino acid is 
metabolized (2). MAT I/III are the main forms in adult hepatocytes, whereas MAT II is the 
prevalent fetal enzyme (15). Moreover, the expression pattern is also altered in carcinogenesis 
(16, 17), during liver regeneration (18, 19), and after glucocorticoid stimulation (20). In addition, 
reductions in MAT I/III activity were shown in animal models of toxicity leading to GSH 
depletion (21, 22) or to enhancement of nitric oxide levels (23). Surprisingly, two patients 
expressing truncated MATα1 subunits exhibit impaired hepatic MAT activity, together with 
neurological symptoms (24), thus suggesting a key role for MAT I/III in extrahepatic tissues. In 
order to shed light on these effects, we performed the present work, which describes the presence 
of MAT I/III in most tissues. The enzyme location to the cell nucleus and the structural features 
that contribute to subcellular localization are also identified. Moreover, the correlation of nuclear 
localization with specific methylation marks, whose alteration may lead to disease development, 
is demonstrated.  
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MATERIAL AND METHODS 
 Tissue extraction and hepatocyte isolation. Rat tissues were obtained from normal 
male Wistar rats (200 g). One portion was immediately frozen in liquid nitrogen for RNA 
isolation, and another was included in 4% (v/v) formaldehyde in PBS for immunohistochemistry. 
Fresh livers were used to obtain nuclear fractions and hepatocyte isolation with collagenase 
(Boehringer Mannheim, Mannheim, Germany) perfusion (25). Hepatocytes were suspended in 
Krebs-Henseleit medium with 10 mM glucose, and incubated at 37ºC with shaking in an O2/CO2 
(95%/5%) gas phase. The viability was evaluated by the Trypan blue test; usually 90-95% cells 
excluded the stain. Normally, 3 x105 cells were seeded on coverslips and incubated for 4h in 
RPMI medium contaning 10% (v/v) FBS before fixation as described for the cell lines. All 
animals were treated according to the Guidelines for Animal Experimentation of the CSIC and 
the European Union. 
 RNA isolation and RT-PCR. Total RNA was isolated using the Tri-Reagent (Sigma 
Chemical Co, St. Louis, Mo, USA) and following the manufacturer’s instructions. The primers 
used for RT-PCR were 5'-ATGGACCTGTGGATGGC-3' and 5'-TGGCCTCCAGTGTTATGT-3' 
for MAT1A and 5'-ATGAACGGGCAGCTCAA-3' and 5'-GCGTAACCAAGGCAATG-3' for 
MAT2A amplification, rendering fragments of 640 and 508 nucleotides, respectively. Reactions 
were performed using the Retrotools cDNA/DNA polymerase kit (Biotools, Madrid, Spain) for 
30 cycles following the manufacturer's instructions. Real-time RT-PCR was performed using the 
18S gene as reference, the MAT1A primers and conditions previously described (26). 
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Immunohistochemistry. For the detection of MATα1 on 5 μm thick paraffin sections, 
endogenous peroxidase activity was blocked by incubation in 2% (v/v) H2O2 in methanol for 10 
minutes in the dark. Sections were heated in 1 mM EDTA for 45 minutes at 150ºC before 
incubation with 1% (w/v) BSA for 30 minutes. Immunostaining was obtained by incubation with 
anti-MAT antiserum (27) (1:1000, v/v) for 2 hours at room temperature followed by EnVision 
(DAKO Corporation, Carpinteria, CA, USA) incubation for 30 minutes using 3,3’-
diaminobenzidine for color development following manufacturer's instructions.  Counterstaining 
was performed with hematoxilin. For negative controls, the preimmune rabbit serum was used. 
Sections were photographed and analyzed using Adobe-Photoshop software. 
 Constructs and site-directed mutagenesis. Plasmids pSSRL-BlueT2 (27) and pSSRL-
T7N (28) were used to obtain the MAT1A ORF for the new constructs that were named 
according to their main characteristics. pTRE-tight-MAT-EGFP for expression in a CHO-K1 
Tet-On cell line (BD Biosciences, San Jose, CA, USA) was obtained by mutation of the MAT 
stop codon in pSSRL-Blue-T2 using the QuikChange method (Stratagene, La Jolla, CA, USA) 
(modified or included bases appear underlined), the primer 5'-
GAAGCTTGTGTTTAGAGCCTCGAGTG-3' and its complement. The plasmid was then Kpn 
I/Bam HI digested, and the insert was ligated on pTRE-tight-EGFP (BD Biosciences, San Jose, 
CA, USA). This construct renders a fused MAT-EGFP protein including a 10 amino acid linker 
sequence at the C-terminal of MAT (RASSAGGSPR). pMAT-EGFP-T7N was prepared by Nde 
I/Eco RI digestion of pTRE-tight-MAT-EGFP and cloning of the corresponding fragment on 
pT7.7 for E. coli expression. pMAT-EGFP for expression of the fusion protein in nonregulated 
systems was obtained from pSSRL-Blue-T2 by Xho I/Hind III digestion with loss of the four C-
terminal amino acids of MAT, two of which were recovered by cloning on pEGFP-N1 (BD 
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Biosciences, San Jose, CA, USA). This strategy creates a 17 amino acid linker at the C-terminal 
end of MAT with the sequence RILQSTVPRARDPPVAT. 
 pFLAG-MAT was prepared by cloning the MATα1 ORF, obtained by Eco RI/Bam HI 
digestion of pSSRL-BlueT2, into a modified pFLAG-CMV4 vector (Sigma Chemical Co, St. 
Louis, Mo, USA) including a Kpn I restriction site. To produce in frame FLAG-MAT, an 
additional base was introduced using the oligonucleotide 5'-
CAAGCTTGCGGCACGCGAATTCATC-3' and its complement. The new fusion protein 
includes 15 extra amino acids in its N-terminus (MDYKDDDDKLDIEFH).  
 p(313-396)-EGFP5x and p(351-396)-EGFP5x, including the sequences encoding for the 
313-396 and 351-396 protein fragments fused to EGFP pentamers, were prepared by PCR 
amplification of the corresponding regions of pSSRL-BlueT2 using the sense oligonucleotides 
5´-CAGCTAGCATGCGGAGAGTCCTTGTTCAGGT-3’ and 5´-
CAGCTAGCATGAACAAGAACTTTGACCTCCGG-3´, respectively and the antisense primer 
5´-CAGCTAGCGCAAACACAAGCTTCTTGGGGA-3´. Primers include Nhe I sites for further 
cloning in pEGFP5x generously provided by Dr. Lazebnick (29). p(393-396)-EGFP5x was 
obtained by mixing 1.5 μg each of the oligonucleotides 5´-CTAGATGAAGCTTGTGTTTGCG-
3´ (sense) and 5´-CTAGCGCAAACACAAGCTTCAT-3´ (antisense), including Nhe I sites, 
denaturation for 3 minutes at 95ºC, annealing by cooling to 25ºC in 46 minutes and 
phosphorylation prior to cloning in pEGFP5x. All the sense oligonucleotides designed for 
fragment expression include ATG initiation codons. 
 MAT mutants and truncated proteins were prepared using the QuikChange method and 
the mutagenic oligonucleotides included in Table 1, except for the F251D inactive mutant for 
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which the primers described previously were utilized (13). Mutations were verified by automatic 
sequencing. 
 Cell culture and transfections. CHO (ovary), N2a (neuroblastoma), COS-7 (kidney) and 
H35 (hepatoma) cell lines were grown in DMEM (Gibco, Carlsbad, CA, USA) supplemented 
with 10% (v/v) FBS and 2 mM glutamine, whereas HEK 293T cells (kidney) were cultured in 
the same medium using polyornithine (Sigma Chemical Co, St. Louis, Mo, USA)-coated plates. 
For CHO-K1 Tet-On culture, 10% (v/v) Tet system-approved FBS (BD Biosciences, San Jose, 
CA, USA) was used. Transfections were performed using Lipofectamine (Invitrogen, Carlsbad, 
CA, USA). Selection of stable clones was performed in the Tet-On system using 1-1.4 mg/ml 
hygromycin (BD Biosciences, San Jose, CA, USA) after 48 hours of culture. One of the stable 
clones showing doxycycline (BD Biosciences, San Jose, CA, USA)-dependent expression of 
MAT was called CHO Tet-On MAT-EGFP and was used in further studies.  
 Immunofluorescence. Direct immunofluorescence of both the CHO Tet-On stable clone 
(in the presence of doxycycline) and of the transient transfections (12000 cells on glass 
coverslips) was performed after 48 hours of culture. For indirect immunofluorescence, cells were 
fixed for 10 minutes with 2% (v/v) formaldehyde, permeabilized for 10 minutes with 0.3% (v/v) 
Triton X-100 and incubated for 30 minutes with 10% (v/v) FBS. Cells were then incubated for 1 
hour at 37ºC with the monoclonal M2 anti-FLAG antibody (5 μg/ml; Sigma Chemical Co, St. 
Louis, Mo, USA) and later for 45 minutes at 37ºC with an antimouse secondary antibody 
conjugated to Alexa fluor 488 (1:800 v/v; Molecular Probes, Carlsbad, CA, USA). Glass 
coverslips were mounted using FluorSave™ reagent (Calbiochem, Darmstadt, Germany). Nuclei 
were stained using 5 μg/ml Hoechst 33342 dye (Molecular Probes, Carlsbad, CA, USA) for 1 
hour before fixation or direct observation. Cell imaging (0.3-0.4 μm sections) was performed on 
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a Leica TCS SPII Spectral microscope using a 63x/1.3 NA objective. Images were analyzed 
using the Leica Confocal Software (LCS Lite, Zurich, Switzerland). Leptomycin B treatment (10 
ng/ml; Calbiochem, Darmstadt, Germany) was performed for 6 hours before fixation or direct 
observation. 
 DNA methylation. The level of methylated DNA was followed by immunofluorescence 
using an anti 5-methyl cytosine antibody (1:1000; Calbiochem, Darmstadt, Germany) on fixed 
cells treated with 4 N HCl and 0.1 % (v/v) Triton X-100 for 30 minutes. Additionally, genomic 
DNA was isolated from transfected cells using the DNeasy kit (Qiagen, Hilden, Germany) and 
the incorporation of methyl groups from [3H-methyl]-AdoMet (GE Healthcare, Barcelona, Spain) 
was followed by the radioactivity assay described by Christman et al. (30) using E. coli SssI 
methylase (New England Biolabs, Beverly, MA, USA). 
 Protein expression. Expression of MAT-EGFP in the Tet-On system was obtained by 
addition of doxycycline 0-4 μg/ml for two days. Protein expression in E. coli was obtained by 
transformation of competent BL21(DE3) cells. Constitutive FLAG-MAT expression was 
obtained after 12-16 hours of culture at 37ºC, whereas MAT-EGFP expression was induced at 
A595 of 0.3-0.4 with 0.5 mM IPTG (Ambion, Austin, TX, USA) for 3 hours at 37ºC.  
 Tissue and cell extracts. Cytosolic fractions of the tissues (20), cell cultures (31) and 
bacteria (28) for activity, western blot and gel filtration measurements were prepared as 
previously described. Separation of nuclear and cytosolic fractions for western blot was carried 
out as described previously (32), whereas for MAT activity measurements detergents were 
eliminated (33). Evaluation of histone methylation was carried out in cell extracts obtained by 30 
minute incubation on ice in 50 mM Tris/HCl pH 7.5, 150 mM NaCl, 0.5% (v/v) SDS, 30 mM 
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sodium pyrophosphate, 50 mM NaF and protease inhibitors, followed by centrifugation at 
100000 x g 30 minutes. 
 Nuclear matrix preparation. Cells grown on coverslips (12 mm) were fixed with 2% 
(v/v) formaldehyde for 10 minutes, washed with PBS and incubated with CSK buffer (10 mM 
Pipes pH 6.8, 100 mM NaCl, 1 mM EGTA, 3 mM MgCl2, 300 mM sucrose) containing 0.5 % 
(v/v) Triton X-100 for 15 minutes. This solution was replaced by CSK buffer including 1% (v/v) 
NP-40 and 0.5% (w/v) sodium deoxycholate for 15 minutes, followed by a 1 minute treatment 
with 300 mM imidazole. Chromatin elimination was performed by RNAse-free/DNAse treatment 
(500 U/ml; Roche, Indianapolis, IN, USA) in CSK buffer for 1 hour at 37ºC, followed by 2 
minutes incubation with 250 mM ammonium sulfate, and 1 minute with 2M NaCl in CSK buffer 
without sucrose and fixation with 3.7% (v/v) formaldehyde for 10 minutes before 
immunostaining. 
 Gel filtration chromatography. Samples of bacterial (1-2 mg) or eukaryal cytosols (1 
mg) and nuclear extracts (0.5 mg) were injected on a Superose 12 HR 10/30 gel filtration column 
(GE Healthcare, Barcelona, Spain), and elution, MAT activity measurements (100 μl) and Dot-
Blot analysis (10 μl) were performed as previously described (34). 
 SDS-PAGE electrophoresis and immunoblotting. Denaturing gel electrophoresis was 
performed on 10% SDS-PAGE gels under reducing conditions, using the Laemmli buffer system. 
Samples containing 80, 40 or 5 μg of tissue, cellular or bacterial cytosols, respectively, were 
loaded per lane. Histone methylation was detected using 10 μg/lane of cell extracts. 
Immunoblotting analysis was carried out as described previously (27) using anti-MAT 
(1:10000), anti-FLAG (5 μg/ml; Sigma Chemical Co, St. Louis, Mo, USA), anti-EGFP (1:5000; 
BD Biosciences, San Jose, CA, USA), anti-cJun (1:1500; Santa Cruz), anti-TBP (1:1000; Santa 
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Cruz Biotechnology, SantaCruz, CA, USA), anti-α-Tubulin (1:10000; Sigma Chemical Co, St. 
Louis, Mo, USA), anti-trimethyl H3K4 (0.1 μg/ml; Upstate, Charlottesville, VA, USA), anti-
trimethyl H3K9 (1:2000; Upstate, Charlottesville, VA, USA) or anti-trimethyl H3K27 (1 μg/ml; 
Upstate, Charlottesville, VA, USA) antibodies, as required. Protein bands were visualized using 
Western Lightning™ chemiluminescence reagent (Perkin Elmer, Waltham, MA, USA). 
 Immunoprecipitation. Nuclear and cytoplasmic fractions (400 μl) were incubated o/n at 
4ºC with anti-FLAG M2 Affinity Gel (40 μl; Sigma Chemical Co, St. Louis, Mo, USA). After 
three washes using TBS, the samples were boiled 10 minutes in Laemmli sample buffer 
including 100 mM DTT, microfuged for 1 minute at 10000 x g and the supernatants loaded onto 
SDS-PAGE gels. 
 Determination of methionine adenosyltransferase and LDH activities. MAT activity 
was measured as described by Gil et al. (20) using 160 μl of cytosolic samples or 100 μl of gel 
filtration fractions and 5 mM concentrations of both ATP and methionine. Detection of activity 
in the nuclear fractions was performed for up to 2 hours with a 4 Ci/mol reaction mixture. LDH 
activity was measured at 340 nm and 37ºC for 5 min using 10-100 μl of the subcellular fractions 
in 50 mM Tris/HCl pH 7.5, 0.2 mM NADH (Sigma Chemical Co, St. Louis, Mo, USA) and 1 
mM pyruvate (Sigma Chemical Co, St. Louis, Mo, USA).  
 Protein concentration determination. The protein concentration of the samples was 
measured using the Bio-Rad protein assay kit and bovine serum albumin as the standard. 
 Sequence analysis and molecular modeling. Analysis of the MATα1 sequence in the 
search for putative localization and export signals was performed using the programs NetNES 
(35) and PredictNLS (36) and the PSort II server, whereas for molecular modeling, the Swiss-
PdbViewer (Glaxo Smithkline R & D) was used.  
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 Statistical analysis. Student’s t-test for unpaired samples was applied for statistical 
analysis using GraphPad Prism v. 5.0 (GraphPad Software, San Diego). Differences were 
considered significant when p <0.05.  
 
 
RESULTS  
 Expression of MAT1A RNA and MATα1 protein shows a wide distribution. MATα1 
was detected in the cytosol of all rat tissues examined by western blot using an anti-MAT I/III 
polyclonal antiserum. The liver protein signal was the strongest, and the signals of heart, lung 
and skeletal muscle showed the lowest levels (Fig. 1A). Notably, a double band was consistently 
observed in all extrahepatic tissues. The same anti-MAT antiserum was used for 
immunohistochemistry, and again, signals for MAT I/III were detected in all the tissues tested, 
except in endothelium, smooth muscle and connective tissue of the visceral walls (Fig. 1B and 
Table 2). Among the cell types clearly labeled, hepatocytes, Purkinje cells, renal tubule, 
bronchiolar and spermatogenic epithelial cells and pancreatic acinar cells could be identified. In 
contrast to the generally accepted cytoplasmic distribution of the protein, nuclear staining was a 
general feature observed in the nonhepatic cells, but also in hepatocytes. Moreover, the strongest 
liver signals were detected in the periportal area with a decreasing gradient of staining towards 
the perivenous area (Fig. S1). Confirmation of the broad expression of MAT1A was obtained by 
RT-PCR using total RNA purified from the same rat tissues in combination with specific 
oligonucleotides for MAT1A or MAT2A amplification (Fig. 1C). All the samples showed signals 
corresponding to both cDNAs, except for aorta, which only showed MAT2A signal. Controls 
performed using these primers and plasmids including ORFs for MAT1A and MAT2A 
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demonstrated their specificity (data not shown). Real-time PCR quantification confirmed the 
highest MAT1A expression in liver, demonstrated intermediate levels in lung, pancreas and 
kidney and faint signals in the rest of the tissues tested (Fig. 1D). Thus, expression of MAT1A 
can no be longer considered liver specific. 
 MATα1 localizes to cytoplasm and nucleus. In order to confirm the subcellular 
distribution observed by immunohistochemistry, several MAT constructs were prepared, and 
their behavior was analyzed in various cell lines by confocal fluorescence microscopy. The 
constructs include tags at the N- (FLAG-MAT) or C-terminal ends (MAT-EGFP) of the MATα1 
ORF, respectively (Fig. 2A). Western blot analysis showed expression of the proteins in bacterial 
and cellular extracts with the expected mobilities: 48 kDa (wild type MATα1), 50 kDa (FLAG-
MAT) and 78 kDa (MAT-EGFP)(Fig. 2B). All constructs were active and retained 
oligomerization capacity upon expression in E. coli (Table 3), but their expression level was 
much lower than that of the wild type protein. The association state of the fusion proteins was 
found to be dimeric by gel filtration chromatography (150 and 90 kDa for MAT-EGFP and 
FLAG-MAT, respectively), which is the minimum required for catalysis. Peaks for the controls 
containing E. coli MAT appeared in volumes corresponding to approximately 180 kDa, and 
hence their activity profiles partially overlap with MAT-EGFP and FLAG-MAT (data not 
shown). Precise identification of the elution position was obtained by Dot blot using anti-MAT 
I/III antiserum. Thus, the fusion forms of MAT I/III are active oligomers, their sizes being larger 
than that required for diffusion through the nuclear pore.  
 Transient transfections of both FLAG-MAT and MAT-EGFP constructs were analyzed in 
several cell lines (CHO-K1, N2a, COS-7, H35 and HEK 293T), in addition to a stable 
doxycycline-inducible MAT-EGFP clone prepared in CHO cells. In all cases, cells demonstrated 
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strong cytoplasmic fluorescence along with a lighter nuclear signal that overlapped with Hoechst 
staining (Fig. 3A). The use of the stable clone allowed detection in cytoplasmic and nuclear 
compartments independently of the expression levels, thus indicating that nuclear localization of 
exogenous MAT is not due to saturation effects (Fig. 3B). Moreover, the nuclear MAT signal 
was excluded from presumptive nucleoli. The results obtained by in vivo and indirect 
fluorescence were consistent, thus excluding artifacts due to cell fixation or the influence of the 
tag localization in the protein structure. Indirect immunofluorescence of isolated hepatocytes 
showed a similar distribution pattern to that observed in the cell lines and by 
immunohistochemistry (Fig. 3C). In addition, subcellular fractionation followed by western blot 
analysis confirmed the presence of MATα1 subunits in the nuclear and cytosolic fractions of 
several cell lines (Fig. 3D). The purity of these fractions was assessed by detection of cJun and 
α-Tubulin as nuclear and cytoplasmic markers, respectively. Therefore, our results confirm the 
nuclear localization of MATα1 as a general feature in all cell types used.  
 Analysis of MATα1 sequence and structure in search for localization determinants. 
Commonly, transport to different subcellular compartments is dependent on the presence of 
protein targeting signals, and several programs have been developed to search for the presence of 
this type of sequences in any given protein. Among them, we have analyzed the MATα1 
sequence using NetNES, PredictNLS and PSort II, none of which identified nuclear export (NES) 
or localization signals (NLS) in this protein. Only a stretch at the C-terminal end of the protein 
comprising V360-L367 showed a low score for a possible NES, but NetNES considered it to be 
below its confidence levels. In fact, addition of the CRM1 (exportin 1) inhibitor leptomycin B to 
the transfected cells induced no changes in MATα1 distribution (data not shown). These results 
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do not support the presence of classical signals of transport, but they do not exclude other 
mechanisms or other determinants of localization.  
 Classical NLSs include sequences rich in basic residues placed at certain distances, 
which can be resembled structurally. The MATα1 sequence contains a considerable number of 
lysine and arginine residues at the C-terminal end (16.7% of the last 96 amino acids). Some of 
these residues appear paired and exposed at the protein surface (Figs. 2C,D), outside of the 
oligomerization interfaces. A first approach to check for the possible implication of this part of 
the molecule in subcellular localization was to prepare C-terminal deletions on FLAG-MAT (Fig. 
2C). These truncated forms correspond to proteins lacking: 1) the last four residues, including 
one of the lysines in the last basic pair (FLAG-MAT K393X); 2) 80% of the C-terminal domain 
including most of the C-terminal basic sequence (FLAG-MAT R313X); and 3) half of this basic 
area (FLAG-MAT N351X). Truncated proteins were expressed in both E. coli and the 
mammalian cell lines used in this study, and their production was confirmed by the detection of 
bands with the expected mobilities (39.5, 44 and 50 kDa)(Fig. 4A). Determination of their 
oligomeric association state was precluded due to the reduced expression levels attained, and the 
low MAT activity that was measured (Table 3). Confocal microscopy and subcellular 
fractionation revealed nuclear accumulation of the three truncated proteins as compared to the 
control (Figs. 4A,B and supplemental data Tables S1, S2). These results suggest that the C-
terminal domain of MATα1 is involved in cytoplasmic retention, but the existence of a NLS in 
the truncated protein or exposure of a NLS otherwise buried in the subunit structure cannot be 
excluded (supplemental data Fig. S2). To distinguish among these possibilities the fragments 
deleted were fused to EGFP5x, and their behavior was analyzed (Fig. 4C). The size of these 
fusion proteins precluded diffusion through the nuclear pore, and hence they would be retained 
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in the cytoplasm, unless these fragments included signals for targeting to a different subcellular 
location. In vivo fluorescence revealed cytoplasmic accumulation in all the cases as compared to 
EGFP5x and NLS-tagged EGFP3x, and in contrast to the behavior of the truncated proteins. 
Thus, the involvement of MATα1 C-terminus in cytoplasmic retention seems feasible. 
 In parallel, the role of the basic residues at the C-terminal domain was explored by point 
mutation, an approach that induced minimum structural perturbations. For this purpose, only 
those lysine or arginine residues exposed at the protein surface were selected for alanine 
substitution (Fig. 2D). Mutants were prepared in both FLAG-MAT and MAT-EGFP plasmids in 
order to avoid artifacts due to either fixation or masking by the fusion of EGFP (27 kDa). All the 
mutants exhibited MAT activity and were able to oligomerize as studied in E. coli 
overexpressing extracts, their dimer/tetramer ratio depending on the protein concentration as 
previously described for wild type MAT I/III (Table 3). Confocal fluorescence microscopy 
revealed that mutations at positions 313, 340, 341, 344, 368, 369, 392 and 393 elicited similar 
behavior of both constructs (Fig. 5A). A reduction in nuclear MATα1 content was observed for 
K340A, K341A, R344A and K393A that was especially clear for R344A and K393A, whereas 
R313A, K368A, K369A and K392A tended to accumulate in the nucleus (Fig. 5A and 
supplemental data Table S1). Subcellular fractionation of the total culture confirmed this 
behavior for most of the mutants (Fig. 5B and supplemental data Table S2). Thus, looking at the 
subunit structure (Fig. 2D), mutants related to nuclear localization are next to those involved in 
cytosolic retention. Notably, whereas K393A accumulates in the cytoplasm, deletion of the 393-
396 stretch resulted in increased nuclear signal, therefore highlighting the role of residues 394-
396 in cytosolic retention. Moreover, the behavior exhibited by the K392A mutant also 
corresponds to a cytosolic retention signal, hence pointing to a possible overlap between areas 
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involved in cytosolic retention and nuclear localization at the C-terminal end of the MATα1 
chain. Thus, nuclear localization is related to the triangular area comprised by residues 340, 344 
and 393 (including 341), whereas cytoplasmic retention is determined by the area delimited by 
residues 313, 368, 369 and 392 that shows partial spatial overlap at K393 and the 394-396 
stretch (Fig. 2D). These results suggested the presence of structural rather than sequence-based 
localization determinants in MATα1 subunits. 
 MATα1 subunits localize to the nuclear matrix. Confocal microscopy showed the 
exclusion of MATα1 from the nucleoli in all the cell lines tested (Fig. 3A). To get further insight 
into the precise subnuclear distribution, CHO and COS-7 cells were transfected with pFLAG-
MAT, fixed and extracted with detergents and high salt in order to obtain the nuclear matrix. 
Indirect immunofluorescence showed the presence of MATα1 at nuclear speckles as shown by 
colocalization with signals of an anti-SC35 antibody (Fig. 6). Additionally, other constructs used 
in this study were also checked for their putative association to the nuclear matrix. The results 
indicated that none of the C-terminal deletions precluded nuclear matrix association, and hence 
suggested that determinants for this binding may be located in other domains of the protein. 
 Nuclear MATα1 association state and effects on specific methylations. Two different 
association levels of MATα1 subunits have been described in the cytoplasm: tetramers and 
dimers. The nuclear localization of MATα1 subunits may or may not be related to AdoMet 
synthesis, for which oligomerization is needed. In order to clarify this point, cotransfections 
using FLAG-MAT and MAT-EGFP were performed, and the nuclear and cytoplasmic fractions 
were isolated. Expression was demonstrated in the input fractions by western blot with anti-
FLAG and anti-EGFP antibodies, and the purity of the subcellular fractions was assessed with 
anti-cJun and anti-α-Tubulin antibodies and LDH activity (Fig. 7A). Nuclear and cytosolic 
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fractions were immunoprecipitated with anti-FLAG Affinity Gel and the immunoprecipitates 
were further analyzed by western blot with an anti-EGFP antibody. The presence of a band 
showing the correct size for MAT-EGFP suggested that MATα1 subunits appear as oligomers in 
the nucleoplasm, and hence preserve AdoMet synthesizing capacity. Controls cotransfected with 
pFLAG-MAT and pEFGP showed no EGFP signal in the immunoprecipitates, thus confirming 
the MAT-MAT interaction specificity. Nuclear extracts prepared without detergents exhibited 
low MAT activity (12.11 ± 3.18 pmol/min/mg) (Fig S3), as expected from the low proportion of 
oligomers and the large amount of monomers detected by gel filtration chromatography (Fig. 
7B). Measurements of nuclear AdoMet concentrations were precluded due both to the low levels 
of the compound in this compartment and the long subcellular fractionation process that did not 
guarantee its preservation.   
 In order to get insight into the function of MATα1 in the nuclear compartment, the effect 
of different constructs on nuclear methylations was evaluated. Overexpression of FLAG-MAT 
produced significant increases in histone H3 trimethylation levels at positions K4, K9 and K27 
(Fig. 8A), as well as in DNA methylation (supplemental data Fig. S4). These effects were not 
observed upon transfection of the inactive mutant F251D, although it was also distributed among 
the cytoplasm and nucleus as shown by both confocal microscopy and subcellular fractionation 
(Figs. 5A,B) and it retained nuclear matrix binding capacity (Fig. 6). Moreover, only K27me3 
methylation levels correlated with the preferred subcellular distribution of the mutants (Fig. 8B 
and supplemental data Fig. S4). Hence, cells transfected with mutants with primary nuclear 
distribution (K368A and K369A) showed increased H3K27me3 (∼2 fold), whereas those 
expressing mutants of preferred cytoplasmic location (R344A and K393A) exhibited levels 
comparable to those of the wild type protein. In addition, expression of the inactive F251D 
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mutant further reduced these specific methylation levels to those of the mock transfected cells. 
The results thus suggested that nuclear MATα1 is in its active oligomeric assembly in order to 
contribute to specific methylations, although preservation of the AdoMet synthesizing capacity is 
not a prerequisite for nuclear localization.   
 
 
DISCUSSION 
 Mammalian MAT activity has been shown to be ubiquitous, but much higher in liver 
than in any other tissue. This fact was ascribed to the presence of specific hepatic isoenzymes 
known as MAT I and III. However, this specificity was questioned when their presence in the 
pancreas was reported (37). Now we show that the distribution of these isoenzymes is nearly 
ubiquitous in normal rat tissues. The presence of a double band in western blots of extrahepatic 
tissues may indicate a certain degree of cross-reactivity of the antibody used with MATα2, 
although no such pattern was previously reported (20, 27, 31). Attempts to detect MAT1A 
mRNA by northern blot in extrahepatic tissues failed previously (38), and hence we used specific 
primers against either of the catalytic MAT subunits and RT-PCR. The data further 
demonstrated a wider expression pattern for MAT1A, resembling that of western blot and 
immunohistochemistry experiments. Moreover, detection of MATα1 in extrahepatic tissues 
showed staining of the nuclear compartment, an observation that was later confirmed in several 
cell lines overexpressing two types of fusion proteins and in normal hepatocytes. Additionally, 
the large hepatic AdoMet production (∼8 g/day in humans) requires a constant supply of ATP 
(2), which is consistent with a greater periportal distribution of the protein, correlating to the 
more aerobic hepatic areas, where oxidative energy metabolism takes place (39). 
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 Analysis of the MATα1 sequence showed no evidence of classical mono- or bipartite 
NLSs (40). However, this fact does not exclude the existence of other less known determinants 
such as hydrophobic rich (41, 42), conformationally dependent (43-45) and PY NLSs (46), or 
piggyback transport mechanisms (47). The fact that several sets of paired basic residues occur at 
the C-terminal end of the protein led us to focus on this part of the molecule. The use of 
truncated MATα1 subunits and fusion of these fragments to multiple EGFP reporters confirmed 
the importance of this segment in subcellular localization. However, the fact that MAT domains 
are formed from nonconsecutive stretches of the sequence makes independent folding unfeasible 
(13), and hence the structure and folding of the truncated subunits (especially R313X and 
N351X), as well as the folding of the fragments, could differ strongly from those in the native 
protein. In addition, it should be noted that in many cases redundant NLSs have been observed 
(48) and the importance of the protein context in which these signals are placed (49). To 
overcome these problems, single mutants of exposed basic residues at the C-terminal were 
studied, and their behavior allowed discrimination of two areas with opposite character. One, 
delimited by residues 340-341-344-393, is involved in nuclear transport and another, 313-368-
369-392, is involved in cytoplasmic retention. The high conservation observed in these residues 
among vertebrate MATs highlights the importance of this part of the structure and its role, the 
exceptions being K340 and the presence in MATα2 of an additional basic residue in the 392-396 
stretch.  
 Although the sets of residues determining localization are scattered along the C-terminal 
domain sequence, they are placed close in the three-dimensional structure of the monomers, thus 
raising the possibility of a topological distribution similar to that of classical NLSs (43, 50). 
However, this does not seem to be the case for MATα1, as distances between analogous 
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positions differ by 2-10 Å. Areas determining cytosolic or nuclear MATα1 localization partially 
overlap in the structure, and hence the function of either one may be regulated by post-
translational modification or interaction with partners that are unknown. Modification by nitric 
oxide is among the known mechanisms to act on NLSs (51) and is known to occur on MATα1 in 
vivo (23). However, nitrosylation occurs on cysteine 121 located at the loop of access to the 
active site, out of the C-terminal domain (23), and hence of the areas related to subcellular 
localization. The existence of other post-translational modifications on this enzyme has not been 
studied in vivo, although in vitro phosphorylation at T342 has been shown (52). On the other 
hand, cytosolic retention determinants are not well characterized and no consensus sequences 
have been postulated. In our case, the data allow us to define areas, including nonconsecutive 
stretches of the C-terminal domain, as being responsible for both nuclear and cytoplasmic 
localization, thus suggesting conformational determinants.  
 The role of MAT isoenzymes in AdoMet synthesis and the need of this metabolite for 
methylation of nuclear components may be linked to the presence of MATα1 in that 
compartment. The positive correlation among nuclear localization of MAT〈1 oligomers, the 
active form of the enzyme, and trimethylation of histone H3K27 suggests its role to guarantee an 
adequate supply of the methyl donor for specific modifications, which is further supported by the 
results with the inactive mutant (F251D). This specificity could arise from the different affinities 
for AdoMet among histone and DNA methyltransferases. Although the small size of AdoMet, 
and even its positive charge, may not preclude diffusion through the nuclear pore (53), the 
possibility exists that its high instability requires in situ synthesis for gene repression, a process 
traditionally related to H3K27 trimethylation (54). Normal development depends on maintenance 
of the correct methylation pattern, whereas tumor progression is associated with aberrant 
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methylation (55). Thus, situations in which AdoMet levels are reduced may lead to disease 
development, as has been demonstrated in animals fed methionine-deficient diets (56, 57) and 
MAT1A knockout mice (10), in which hepatitis and HCC occur. In these models, as well as in 
pancreatitis (37), a switch between MAT1A and MAT2A expression is detected that is not 
enough to cope with all the AdoMet needs of the cell, suggesting a specific role for MAT I/III in 
epigenetic modification. This effect could acquire additional importance if, in spite of their high 
homology (11), MATα2 cannot substitute for the nuclear role of MATα1 in gene repression. 
Such a potential specific function is further supported by the minimal MATα1 expression 
detected in most tissues, where the protein is mainly nuclear.  
 Proteins involved in intermediary metabolism have been identified in the nucleus, although 
their role in this compartment has not always been established. Among them is S-
adenosylhomocysteine hydrolase, whose nuclear presence has been ascribed to the need for S-
adenosylhomocysteine removal during cap methylation to avoid inhibition of these reactions 
(58). However, other examples link nuclear location to the ability of the proteins to exhibit 
additional functions (moonlighting), properties that can be acquired, e.g. by oligomer 
dissociation (59). Detection of nuclear MATα1 as tetramers suggests its role in AdoMet 
synthesis, although the large amount of monomers may be related to the capacity to display other 
functions. Monomer structure should differ strongly from that of monomers in active oligomers, 
since the large hydrophobic surface of contact between subunits should be hidden from the 
solvent. Such a structural change provides new interaction possibilities that may be related to 
pathways other than those involving methylations. Such a new function opens new possibilities 
to explain the demyelination observed in the few patients expressing truncated MATα1 forms 
∼350 residues long. These neurological symptoms were ascribed previously to a reduction in 
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AdoMet levels due to hetero-oligomerization with MATα2, although these effects were difficult 
to conciliate with the hepatic expression of the enzyme (24). 
 In summary, our western and RT-PCR data show MAT1A expression in almost every 
tissue. Immunohistochemistry and overexpression of the protein also demonstrate its nuclear 
localization, offering additional possibilities to understand its pathological role. Overlapping 
regions responsible for nuclear and cytoplasmic localization are identified by mutagenesis of the 
C-terminal end of MAT I/III. Moreover, the preferred subcellular localization of the mutants 
correlates with changes in specific epigenetic methylations, effects that could depend directly on 
nuclear AdoMet synthesis or on other putative new functions of nuclear MATα1 monomers.  
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FIGURE LEGENDS 
Figure 1. MATα1 expression in rat tissues. Panel A shows a western blot of cytosolic fractions 
(80 μg per lane) from several rat tissues developed with anti-MAT I/III antiserum. Panel B 
includes preimmune (a, c, e, g, i and k) and immune staining (b, d, f, h, j and l) of tissue 
sections, where a discontinuous line indicates the contour of typical cells (the bar corresponds to 
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10 μm). Panel C shows RT-PCR results using specific primers for MAT1A (I) and MAT2A (II) 
amplification. Panel D presents data of real-time PCR for MAT1A mRNA in triplicate ± SD, 
using the kidney levels as reference for graphical purposes. Liver, pancreas and lung levels are 
significantly different from the rest of the tissues and between them according to Student’s t-tests 
of the data (p < 0.02). 
 
Figure 2. MATα1 constructs used in this work and their oligomeric structures. Panel A 
depicts a schematic view of the constructs used in this work, including the sequences of the C-
terminal end of MATα1 and the linkers. Panel B shows a representative western blot (10 
μg/lane) of MATα1 (lane 1), FLAG-MAT (lane 2) and MAT-EGFP (lane 3) expression in the 
soluble fraction of E. coli using anti-MAT I/III and anti-EGFP antibodies. The calculated 
molecular masses appear on the left side of the figure. Panel C shows the sequence of the last 97 
residues of the C-terminal domain, indicating the position of the exposed basic amino acids 
(red), the positions at which stop codons were introduced (*) and the putative low score NES 
sequence (underlined). Panel D depicts views of the tetramer and dimer structures (subunits A 
and B in palecyan and salmon, respectively) highlighting the residues mutated in this work, as 
well as the 394-396 stretch. 
 
Figure 3. Subcellular distribution of MATα1. Panel A shows in vivo expression of MAT-
EGFP (left) and indirect immunofluorescence of FLAG-MAT using anti-FLAG (right) in 
different cell lines by confocal microscopy, as well as colocalization with nuclear staining (bar 
scale 25 μm). Panel B illustrates MAT-EGFP expression in the CHO Tet-On MAT-EGFP stable 
clone as a function of doxycycline concentration by both western blot and confocal microscopy 
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(bar scale 17 μm). Panel C includes preimmune and immune staining of hepatocytes using anti-
MAT I/III antiserum, the overlap with nuclear staining appearing in white (bar scale 16 μm). 
Panel D shows a representative western blot of nuclear and cytoplasmic fractions obtained from 
COS-7 cells and hepatocytes developed with anti-FLAG, anti-EGFP or anti-MAT antibodies, as 
indicated. Anti-cJun and anti-α-Tubulin antibodies were used as nuclear and cytoplasmic 
markers, respectively. Average LDH activity in the nuclear fractions was < 0.8% of that in the 
cytosol. 
 
Figure 4. Subcellular distribution of truncated forms and C-terminal fragments. Panel A 
shows a representative western blot of nuclear and cytoplasmic fractions (80 μg/lane) of FLAG-
MAT truncated proteins expressed in COS-7 cells using anti-FLAG with their calculated masses 
appearing on the right. Confocal microscopy images of the truncated proteins (panel B, bar scale 
15 μm) and the C-terminal fragments fused to pentameric EGFP (panel C, bar scale 25 μm) are 
also shown. Colocalization with Hoechst nuclear staining appears in white. Panel C also includes 
images of pentameric EGFP and the NLS-EGFP3x controls.   
 
Figure 5. Distribution of mutant proteins in subcellular compartments.  Panel A shows 
confocal microscopy images of CHO cells overexpressing the FLAG-MAT and MAT-EGFP 
mutants used in this study, the Hoechst overlapping nuclear signal appearing in white (bar scale 
25 μm). FLAG-MAT signals were detected using anti-FLAG. Panel B includes representative 
western blots of COS-7 subcellular fractions for the mutants developed with anti-FLAG, anti-α-
Tubulin and anti-TBP (TATA binding protein). Dotted lines indicate positions at which lanes 
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from this representative blot have been cropped. Average LDH activity in the nuclear fractions 
was < 0.8% of that in the cytosol. 
 
Figure 6. MATα1 locates at the nuclear matrix. Nuclear matrix preparations of CHO cells 
expressing wild type, truncated and the F251D mutant of MATα1 were analyzed by confocal 
microscopy using anti-FLAG and anti-SC-35 antibodies. FLAG-MAT signals (green) overlap 
with SC-35 (red), a nuclear matrix marker, colocalization appearing in orange (bar scale 20 μm).  
 
Figure 7. Nuclear MATα1 association state.  Cotransfections of COS-7 cells with pFLAG-
MAT and pMAT-EGFP or pFLAG-MAT and pEGFP as a control were performed to analyze the 
association state shown by MATα1 subunits in the nucleus. The figure shows 
inmunoprecipitation of FLAG-MAT followed by western blot detection of MAT-EGFP (panel A 
left) or EGFP (panel A right) of nuclear (N) and cytosolic (C) fractions using anti-EGFP. The 
expression of both types of MATα1 subunits, as well as the purity of the fractions, is 
demonstrated by western blot of the input samples using anti-FLAG and anti-EGFP antibodies. 
The purity of the subcellular fractions was analyzed using anti-cJun and anti-tubulin for 
detection of these nuclear and cytoplasmic markers, respectively. Average LDH activity in the 
nuclear fractions was < 0.8% of that in the cytoplasm. Panel B shows the gel filtration 
chromatography profile of nuclear extracts without detergents (LDH activity < 0.05% of that in 
the cytoplasm). The presence of MATα1 in the fractions was detected by Dot-blot (200 μl) using 
anti-MAT. The arrows indicate the elution position of tetramers (a) and monomers (b). The 
protein standards used and their elution volumes were as follows: Dextran Blue (2000 kDa), 8.69 
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ml; apoferritin (443 kDa), 9.87 ml; β-amylase (200 kDa), 11.34 ml; alcohol dehydrogenase (150 
kDa), 12.07 ml; carbonic anhydrase (29 kDa), 15.12 ml; and ATP (0.551 kDa), 19.26 ml. 
 
Figure 8. Effects of MATα1 overexpression on histone H3 trimethylation.  FLAG-MAT and 
selected mutants were overexpressed in CHO cells to evaluate the impact exerted on histone H3 
trimethylation levels at residues K4, K9 and K27 by western blot. Panel A shows the effect of 
wild type MAT overexpression as compared to the empty plasmid on these three methylations. 
Panel B shows the effects on K27 trimethylation of MAT mutants showing preferred cytoplasmic 
(R344A and K393) and nuclear localizations (K368A and K369A), as well as those of the 
inactive F251D mutant. The histograms show the mean of the results corrected against α-
Tubulin (panel A) and MAT levels (panel B) of seven independent experiments ± SEM. The 
results were considered significant when p< 0.05 (*) according to the Student’s t-test performed 
against pFLAG (panel A) and WT (panel B). 
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Table 1 
Oligonucleotides used for mutagenesis. The table lists the oligonucleotides (sense only) used 
for mutagenesis in this work. 
Mutated 
plasmid 
Residue 
change 
Primers (5’-3’; sense only) 
pMAT-EGFP R313A GGCTGGGCTCTGCGCCAGAGTCCTTGTTC  
K340A CCTACGGAACTTCCGCCAAGACTGAGCGAGAG  
K341A CTACGGAACTTCCAAGGCCACTGAGCGAGAGC  
R344A CCAAGAAGACTGAGGCAGAGCTACTAGAGG  
R357A CAAGAACTTTGACCTCGCCCCGGGTGTTATTGTC 
R363A CCGGGTGTTATTGTCGCCGACTTGGATCTGAAG 
K368A GGGACTTGGATCTGGCCAAGCCCATCTACCAG  
K369A GACTTGGATCTGAAGGCCCCCATCTACCAGAAG  
K374A GCCCATCTACCAGGCCACTGCATGCTATGG  
K392A CCTGGGAGGTCCCCGCCAAGCTTCGAATTC  
K393A GGGAGGTCCCCAAGGCCCTTCGAATTCTGC 
 
pFLAG-MAT R313A GGCTGGGCTCTGCGCCAGAGTCCTTGTTC  
K340A CCTACGGAACTTCCGCCAAGACTGAGCGAGAG  
K341A CTACGGAACTTCCAAGGCCACTGAGCGAGAGC  
R344A CCAAGAAGACTGAGGCAGAGCTACTAGAGG 
R357A CAAGAACTTTGACCTCGCCCCGGGTGTTATTGTC  
R363A CCGGGTGTTATTGTCGCCGACTTGGATCTGAAG  
K368A GGGACTTGGATCTGGCCAAGCCCATCTACCAG 
K369A GACTTGGATCTGAAGGCCCCCATCTACCAGAAG  
K374A GCCCATCTACCAGGCCACTGCATGCTATGG 
K392A CCTGGGAGGTCCCCGCCAAGCTTGTGTTTTAG 
K393A GGGAGGTCCCCAAGGCCCTTGTGTTTTAGAGC  
R313X GGCTGGGCTCTGCTAGAGAGTCCTTGTTC 
N351X GAGCTACTAGAGGTTGTGTGAAAGAACTTTGACCTCCG 
K393X GGGAGGTCCCCAAGTAGCTTGTGTTTTAG 
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Table 2 
 Immunohistochemistry staining and subcellular distribution. The organs listed in 
the table were extracted from adult Wistar rats, fixed and analyzed by immunohistochemistry 
using preimmune (control) and anti MAT I/III antisera. The most relevant cell types showing 
positive (+) and negative (-) staining for MATα1 among cytoplasm and nuclei appear 
summarized in the table.  
 Anti-MAT signal 
Organ/tissue type Structure/cell type Cytoplasm Nucleus 
Liver Hepatocytes + + 
Brain Cerebellar Purkinje cells + + 
Kidney Epithelium of renal tubules + + 
Lung Bronchiolar epithelium + + 
Epididymus Spermatogenic epithelium - + 
Digestive system Mucosa - + 
Pancreas Pancreatic acini cells + + 
Heart Muscle cells - + 
Skeletal muscle Muscle cells - + 
Blood vessels Endothelium - - 
Smooth muscle Visceral and vascular wall - - 
Connective tissue Visceral and vascular wall - - 
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Table 3 
 Methionine adenosyltransferase activity of the protein variants used in this study. 
All the protein variants used in this study were expressed in E. coli BL21(DE3) and the 
soluble fractions isolated to determine their activity and oligomerization state. The table shows 
activity results from a typical experiment carried out in triplicate ± SD, and the association 
state detected by gel filtration chromatography (T = tetramer and D = dimer).  
Construction MAT activity 
(nmol/min/mg) 
Association level 
pSSRL-T7N 21.8 ± 4.30** T, D 
pMAT-EGFP-T7N* 1.41 ± 0.01** D 
pFLAG-CMV4 0.51 ± 0.03 - 
pFLAG-CMV4-MAT* 2.36 ± 0.10 D 
pFLAG-CMV4-MAT R313A 
 
3.89 ± 0.17 T 
pFLAG-CMV4-MAT K340A 5.35 ± 0.22 T, D 
pFLAG-CMV4-MAT K341A 3.07 ± 0.37 T, D 
pFLAG-CMV4-MAT R344A 3.19 ± 0.09 T, D 
pFLAG-CMV4-MAT R357A 1.30 ± 0.09 T 
pFLAG-CMV4-MAT R363A 3.66 ± 0.10 T, D 
pFLAG-CMV4-MAT K368A 1.39 ± 0.09 T, D 
pFLAG-CMV4-MAT K369A 2.64 ± 0.30 T, D 
pFLAG-CMV4-MAT K374A 3.63 ± 0.47 T, D 
pFLAG-CMV4-MAT K392A 2.35 ± 0.03 T, D 
pFLAG-CMV4-MAT K393A 1.12 ± 0.03 T, D 
pFLAG-CMV4-MAT R313X* 0.62 ± 0.04 ND 
pFLAG-CMV4-MAT N351X* 0.73 ± 0.04 ND 
pFLAG-CMV4-MAT K393X* 0.86 ± 0.03 ND 
* Proteins with low or very low expression levels. 
** constructs needing IPTG induction. 
ND, not determined 
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